SCHEMBL488025

SCHEMBL488025

Fc1ccc(F)c(CBr)c1Cl

nearest known ligand 0.34

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.34
TNF P01375 1/20 0.34
RIPK1 Q13546 1/20 0.34
GAA P10253 1/20 0.32
P2RX7 Q99572 2/20 0.32
HTR2A P28223 3/20 0.31
HTR2C P28335 3/20 0.31
HTR2B P41595 3/20 0.31
CYP2A13 Q16696 1/20 0.31
FFAR4 Q5NUL3 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14911877 0.86 TAAR1 (0.36) TAAR1TNFRIPK1GAAP2RX7
SCHEMBL29395269 0.86 TAAR1 (0.36) TAAR1TNFRIPK1GAAP2RX7
SCHEMBL752405 0.86 TAAR1 (0.36) TAAR1GAAP2RX7CYP2A13
SCHEMBL261259 0.84 TAAR1 (0.31) TAAR1
SCHEMBL488564 0.82 P2RX7 (0.40) TAAR1P2RX7
SCHEMBL28814492 0.81 TAAR1 (0.36) TAAR1TNFRIPK1GAAP2RX7
SCHEMBL383805 0.81 TRPA1 (0.32) TAAR1
SCHEMBL30287789 0.81 TRPA1 (0.32) TAAR1
SCHEMBL8129726 0.79 TAAR1 (0.32) TAAR1GAA
SCHEMBL14974002 0.78 HTR2A (0.44) GAAHTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4879423-A 2-CHLORO-3,6-DIFLUOROBENZYL 3-(2-CHLORO-3,3,3-TRIFLUOROPROP-1-EN-1-YL) -2,2-DIMETHYLCYCLOPROPANECARBOXYLATE, INSECTICIDES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-11-07 US claimed
CN-112654621-B Substituted naphthyridinone compounds useful as T cell activators 百时美施贵宝公司 2024-05-14 CN disclosed
EP-3814348-B9 SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS BRISTOL MYERS SQUIBB CO (US) 2023-11-01 EP disclosed
EP-3814348-B1 SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS BRISTOL MYERS SQUIBB CO (US) 2023-08-02 EP disclosed
US-11713316-B2 Substituted naphthyridinone compounds useful as T cell activators BRISTOL-MYERS SQUIBB COMPANY (US) 2023-08-01 US disclosed
US-20220324859-A1 SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS BRISTOL MYERS SQUIBB CO (US) 2022-10-13 US disclosed
US-11149018-B2 Substituted N-arylethyl-2-aminoquinoline-4-carboxamides and use thereof BAYER AKTIENGESELLSCHAFT (DE) 2021-10-19 US disclosed
US-11136296-B2 Substituted N-arylethyl-2-arylquinoline-4-carboxamides and use thereof BAYER AKTIENGESELLSCHAFT (DE) 2021-10-05 US disclosed
EP-3814348-A1 SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS Bristol-Myers Squibb Company (US) 2021-05-05 EP disclosed
CN-112654621-A Substituted naphthyridinone compounds useful as T cell activators 百时美施贵宝公司 2021-04-13 CN disclosed
EP-1366026-B1 PYRIMIDINE COMPOUNDS AND THEIR USE AS PESTICIDES SUMITOMO CHEMICAL CO (JP) 2004-12-01 EP disclosed
WO-2004076412-A2 AMINOHETEROARYL COMPOUNDS AS PROTEIN KINASE INHIBITORS SUGEN, INC. (US) 2004-09-10 WO disclosed
US-20040077669-A1 Pyrimidine compounds and their use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-04-22 US disclosed
WO-2004011443-A1 PYRIMIDYL SULPHONE AMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2004-02-05 WO disclosed
EP-1366026-A2 PYRIMIDINE COMPOUNDS AND THEIR USE SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2003-12-03 EP disclosed
WO-2002024663-A2 PYRIMIDINE COMPOUNDS AND THEIR USE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-03-28 WO disclosed
WO-1996015672-A1 FUNGICIDAL COMPOSITION ZENECA LIMITED (GB) 1996-05-30 WO disclosed
WO-1996015671-A1 HERBICIDES ZENECA LIMITED (GB) 1996-05-30 WO disclosed
US-4879423-A 2-CHLORO-3,6-DIFLUOROBENZYL 3-(2-CHLORO-3,3,3-TRIFLUOROPROP-1-EN-1-YL) -2,2-DIMETHYLCYCLOPROPANECARBOXYLATE, INSECTICIDES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-11-07 US disclosed
US-4778822-A SOIL ROOT WORM CONTROL WITH 2-CHLORO-3,6-DIFLUOROBENZYL 3-(2-CHLORO-3,3,3-TRIFLUOROPROP-1-EN-1-YL) -2,2-DIMETHYLCYCLOPROPANE CARBOXYLATE IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220324859-A1 SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS DGKZ, DGKA, DGKG TAAR1 2942/4885TNF 3015/4885RIPK1 447/4885
US-11149018-B2 Substituted N-arylethyl-2-aminoquinoline-4-carboxamides and use thereof AADAC, ARG2, GOT2 TAAR1 2337/4885TNF 518/4885RIPK1 3822/4885
US-11136296-B2 Substituted N-arylethyl-2-arylquinoline-4-carboxamides and use thereof AADAC, NAT1, EPX TAAR1 2529/4885TNF 435/4885RIPK1 3703/4885
US-20040077669-A1 Pyrimidine compounds and their use TYMP, TYMS, DPYD TAAR1 2360/4885TNF 4881/4885RIPK1 2645/4885
US-11713316-B2 Substituted naphthyridinone compounds useful as T cell activators DGKZ, DGKA, DGKG TAAR1 2942/4885TNF 3015/4885RIPK1 447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.